Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19

This post was originally published on this site

<p xmlns=""><span class="xn-location">INDIANAPOLIS, <span class="xn-chron">Nov. 19, 2020 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the distribution and emergency use of…

Bastion Balance Seoul, Korea.